Page 62 - ILAE_Lectures_2015
P. 62

51. WASTERLAIN CG. Recurrent seizures in the developing brain are harmful. Epilepsia 1997; 38: 728-734.
52. WIRRELL EC, ARMSTRONG EA, OSMAN LD et al. Prolonged seizures exacerbate perinatal hypoxic-ischemic

         brain damage. Pediatric Res 2001; 50: 445-454.
53. BITTIGAU P, SIFRINGER M, GENZ K et al. Antiepileptic drugs and apoptotic neurodegeneration in the

         developing brain, Proc Natl Acad Sci USA 2002; 99(23): 15089-15094.
54. KIM JS, KONDRATYEV A, TOMITA Y, GALE K. Neurodevelopmental impact of antiepileptic drugs and

         seizures in the immature brain. Epilepsia 2007; 48 (Suppl 5): 19-26.
55. BERG AT, BERKOVIC SF, BRODIE MJ et al. Revised terminology and concepts for organization of seizures

         and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010;
         51(4): 676-685.
56. GLASS HC, HONG KJ, ROGERS EE et al. Risk factors for epilepsy in children with neonatal encephalopathy.
         Pediatr Res 2011; 70(5): 535-540.
57. CLANCY RR, DICKER L, CHO S et al. Agreement between long-term neonatal background classification by
         conventional and amplitude-integrated EEG. J Clin Neurophysiol 2011; 28(1): 1-9.
58. PEARL PL. New treatment paradigms in neonatal metabolic epilepsies. J Inherit Metab Dis 2009; 32(2): 204-13.
59. VAN HOVE JLK, LOHR NJ. Metabolic and monogenic causes of seizures in neonates and young infants. Mol
         Genet Metab 2011; 104: 214-230.
60. WHO. Guidelines on Neonatal Seizures. World Health Organization, Geneva, 2011.
61. VENTO M, DE VRIES LS, ALBEROLA A et al. Approach to seizures in the neonatal period: a European
         perspective. Acta Paediatr 2010; 99(4): 497-501.
62. ILAE: Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and
         Terminology of the International League Against Epilepsy. Epilepsia 1989; 30(4):3 89-399.
63. VAN ROOIJ LG, VAN DEN BROEK MP, RADEMAKER CM, DE VRIES LS. Clinical management of seizures
         in newborns: diagnosis and treatment. Paediatr Drugs 2013; 15(1): 9-18.
64. VAN ROOIJ LG, HELLSTRÖM-WESTAS L, DE VRIES LS. Treatment of neonatal seizures. Semin Fetal
         Neonatal Med 2013; 18(4): 209-215.
65. PRESSLER RM, BOYLAN GB, MARLOW N et al. Bumetanide for the treatment of seizures in newborn babies
         with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial.
         Lancet Neurol 2015; 14: 469-476.
66. PRESSLER RM, MANGUM B. Newly emerging therapies for neonatal seizures. Semin Fetal Neonatal Med 2013;
         18(4): 216-223.
67. PISANI F, PICCOLO B, CANTALUPO G et al. Neonatal seizures and postneonatal epilepsy: a 7-y follow-up
         study. Pediatr Res 2012; 72(2): 186-93.
68. URIA-AVELLANAL C, MARLOW N, RENNIE JM. Outcome following neonatal seizures. Semin Fetal Neonatal
         Med 2013; 18(4): 24-32.
   57   58   59   60   61   62   63   64   65   66   67